I. Larripa

发表

A new polymorphism in the human factor VIII gene: implications for linkage analysis in haemophilia A and for the evolution of int22h sequences

P. Collins, D. Bowen, C. D. De Brasi, 2000, British journal of haematology.

Topoisomerase II-Mediated DNA Damage Is Differently Repaired during the Cell Cycle by Non-Homologous End Joining and Homologous Recombination

M. González-Cid, I. Larripa, Marcelo de Campos-Nebel, 2010, PloS one.

Single nucleotide polymorphism in PTEN-Long gene: A risk factor in chronic myeloid leukemia.

C. D. De Brasi, I. Larripa, C. Ferri, 2019, Gene.

Assessment of cytogenetic damage in chagasic children treated with benznidazole.

I. Larripa, N. Gorla, O. Ledesma, 1988, Mutation research.

Caffeic Acid Phenylethyl Ester and MG-132 Have Apoptotic and Antiproliferative Effects on Leukemic Cells But Not on Normal Mononuclear Cells.

D. Papademetrio, S. Hajos, G. Blanco, 2009, Translational oncology.

miRNome profiling of LSC-enriched CD34+CD38−CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool

P. Valent, P. Yankilevich, C. Furtado, 2021, Frontiers in Pharmacology.

Are int22h-mediated deletions a common cause of hemophilia?

C. P. Radic, C. D. De Brasi, L. Rossetti, 2012, Annals of Hematology.

Developing a new generation of tests for genotyping hemophilia‐causative rearrangements involving int22h and int1h hotspots in the factor VIII gene

C. P. Radic, C. D. De Brasi, L. Rossetti, 2008, Journal of thrombosis and haemostasis : JTH.

Improved Diagnosis of the Transition to JAK2 V617F Homozygosity: The Key Feature for Predicting the Evolution of Myeloproliferative Neoplasms

M. Bianchini, I. Zalcberg, C. Stanganelli, 2014, PloS one.

Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patients

V. Rocha, D. Fantl, I. Larripa, 2021, Annals of Hematology.

Application of the revised International Prognostic Scoring System for myelodysplastic syndromes in Argentinean patients

R. Bengió, I. Larripa, J. Arbelbide, 2014, Annals of Hematology.

CAMKIIγ, HSP70 and HSP90 transcripts are differentially expressed in chronic myeloid leukemia cells from patients with resistant mutated disease

M. Bianchini, C. D. De Brasi, R. Bengió, 2014, Leukemia & lymphoma.

A single, multiplex analysis for all relevant activating NRAS gene mutations using heteroduplex generators

D. Bowen, I. Larripa, C. Belli, 2004, British journal of haematology.

Rapid detection of exon 1 NRAS gene mutations using universal heteroduplex generator technology

I. Larripa, C. Belli, C. Brasi, 2003, Human mutation.

Additive apoptotic effect of STI571 with the cytoprotective agent amifostine in K-562 cell line

M. González-Cid, L. Vellon, I. Larripa, 2005, Cancer Chemotherapy and Pharmacology.

Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.

M. Bianchini, R. Bengió, I. Larripa, 2014, Blood cells, molecules & diseases.

An unusual translocation, t(1;11)(q21;q23), in a case of chronic myeloid leukemia with a cryptic Philadelphia chromosome.

M. F. Noriega, R. Bengió, I. Larripa, 2017, Oncology letters.

Early detection and quantification of mutations in the tyrosine kinase domain of chimerical BCR–ABL1 gene combining high-resolution melting analysis and mutant-allele specific quantitative polymerase chain reaction

M. Bianchini, R. Bengió, I. Larripa, 2013, Leukemia & lymphoma.

Bcl-2 molecular analysis in paraffin-embedded biopsies from diffuse large B-cell lymphomas.

M. Narbaitz, I. Slavutsky, C. D. De Brasi, 2000, Medicina.

Evaluation of constitutional chromosome aberrations in hematologic disorders.

Christian Chena, I. Slavutsky, R. Cerretini, 2002, Cancer genetics and cytogenetics.

Heterochromatic variants and their association with neoplasias: V. Non-Hodgkin's lymphomas.

I. Slavutsky, I. Larripa, M. L. Labal de Vinuesa, 1988, Cancer genetics and cytogenetics.

Biological activity in Macrocystis pyrifera from Argentina: sodium alginate, fucoidan and laminaran. II: Genotoxicity

A. Mayer, I. Larripa, M. M. D. Pargament, 1987 .

Heterochromatic variants and their association with neoplasias. II. Preleukemic states.

I. Larripa, M. L. Labal de Vinuesa, M. D. Mudry de Pargament, 1985, Cancer genetics and cytogenetics.

Heterochromatic variants and their association with neoplasias. I. Chronic and acute leukemia.

I. Larripa, M. L. Labal de Vinuesa, M. D. Mudry de Pargament, 1984, Cancer genetics and cytogenetics.

Sister chromatid exchanges (SCE) in two murine strains.

I. Larripa, M. L. de Vinuesa, M. M. de Pargament, 1983, European journal of cancer & clinical oncology.

BAX/BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia.

M. Bianchini, C. D. De Brasi, R. Bengió, 2010, Blood cells, molecules & diseases.

Expression Dynamics Of The Immune Mediators ARG1, TBET, CIITA, IL10 AND TGFB1 IN Chronic Myeloid Leukaemia Patients During The First Year Of Imatinib Therapy.

I. Larripa, M. Pérez, R. Mariano, 2021, Gene.

Genotoxicity of AMPA, the environmental metabolite of glyphosate, assessed by the Comet assay and cytogenetic tests.

I. Larripa, F. Mañas, J. Raviolo, 2009, Ecotoxicology and environmental safety.

Glutathione S-transferase gene polymorphisms in celiac disease and their correlation with genomic instability phenotype.

I. Slavutsky, I. Larripa, N. Weich, 2014, Clinics and research in hepatology and gastroenterology.

Increased expression of 5q31 fragile site in a Bloom syndrome family

M. Bonduel, I. Larripa, H. Lejarraga, 1992, Human Genetics.

Spontaneous breakage and fragile site expression in chronic lymphocytic leukemia.

I. Slavutsky, I. Larripa, A. Fundia, 1998, Cancer genetics and cytogenetics.

Gene polymorphism profiles of drug-metabolising enzymes GSTM1, GSTT1 and GSTP1 in an Argentinian population

L. Chertkoff, I. Slavutsky, Alejandro Roisman, 2017, Annals of human biology.

Identification of driver and subclonal mutations in ASXL1 and IDH1/IDH2 genes in an Argentine series of patients with myelofibrosis

C. Meyer, K. Scheps, C. D. De Brasi, 2018, International journal of laboratory hematology.

New mutation L324M in the ABL1 kinase domain: does it confer high resistance to second-generation inhibitors?

M. F. Noriega, I. Larripa, C. Ferri, 2014, Leukemia & lymphoma.

Cryptic t(4;11) encoding MLL-AF4 due to insertion of 5′ MLL sequences in chromosome 4

A. Hagemeijer, E. Schuuring, R. Marschalek, 2001, Leukemia.

Factor VIII genotype characterization of haemophilia A affected patients with transient and permanent inhibitors: a comprehensive Argentine study of inhibitor risks

D. Neme, C. P. Radic, L. Rossetti, 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

Prognostic relevance of cytogenetic systems in myelodysplastic syndromes

R. Bengió, I. Larripa, A. Basquiera, 2012, Leukemia & lymphoma.

Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 quantification in CML patients: findings and recommendations

M. Gutiérrez, C. Santamaria, M. E. Altuna, 2020, Clinical chemistry and laboratory medicine.

Clinical activity of ponatinib in one patient with chronic myeloid leukemia in chronic phase with e19a2 transcript and T315I mutation

M. Bianchini, M. F. Noriega, R. Bengió, 2015, European journal of haematology.

Detection of risk groups in myelodysplastic syndromes. A multicenter study.

Juan F. García, G. Arrossagaray, R. Bengió, 2002, Haematologica.

Leukemic transformation in patients with 5Q- and additional abnormalities.

I. Slavutsky, R. Bengió, I. Larripa, 1991, Haematologica.

Efficacy of lenalidomide in a patient with systemic mastocytosis associated with SF3B1-mutant myelodysplastic syndrome

M. Narbaitz, I. Larripa, M. Sarmiento, 2021, Leukemia & lymphoma.

BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival

J. Cortes, B. Simões, E. Cervera, 2015, Cancer investigation.

Novel Variant Ph Translocation t(9;22;11)(q34;q11.2;p15)inv(9)(p13q34) in Chronic Myeloid Leukemia Involving a One-Step Mechanism

M. Bianchini, M. Alù, I. Larripa, 2011, Cytogenetic and Genome Research.

Specific assessment of BCR–ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients

M. Bianchini, R. Bengió, I. Larripa, 2009, European journal of haematology.

The presence of -308A TNFα is associated with anemia and thrombocytopenia in patients with myelodysplastic syndromes.

R. Bengió, I. Larripa, N. Watman, 2011, Blood cells, molecules & diseases.

Promyelocytic blast crisis of chronic myelogenous leukaemia with translocations (9;22) and (15;17).

A. Palumbo, M. F. Palacios, I. Larripa, 1998, Leukemia & lymphoma.

Polymorphisms in TNF and IFNG are associated with clinical characteristics of aplastic anemia in Argentinean population

Verónica Verri, R. Bengió, I. Larripa, 2015, Leukemia & lymphoma.

Phenotype–genotype correlations in hemophilia A carriers are consistent with the binary role of the phase between F8 and X‐chromosome inactivation

D. Neme, M. Bonduel, E. Medina-Acosta, 2015, Journal of thrombosis and haemostasis : JTH.

Analysis of factor VIII gene intron 1 inversion in Argentinian families with severe haemophilia A and a review of the literature.

A. Goodeve, L. Rossetti, I. Larripa, 2004 .

Analysis of factor VIII gene intron 1 inversion in Argentinian families with severe haemophilia A and a review of the literature

A. Goodeve, C. D. De Brasi, L. Rossetti, 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Specific analysis of the intron 22 XbaI polymorphism of the human factor VIII gene using long‐distance PCR

P. Collins, D. Bowen, C. D. De Brasi, 1999, British journal of haematology.

Enhanced uptake of antisense oligonucleotides using cationic liposomes and the apoptotic effect of idarubicin in K-562 cell line.

M. González-Cid, L. Vellon, I. Larripa, 2002, Leukemia research.

TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome.

R. Bengió, I. Larripa, C. Ferri, 2016, Blood cells, molecules & diseases.

Genotoxicity of glyphosate assessed by the comet assay and cytogenetic tests.

I. Larripa, F. Mañas, J. Raviolo, 2009, Environmental toxicology and pharmacology.

Thirteenfold increase of chromosomal aberrations non-randomly distributed in chagasic children treated with nifurtimox.

I. Larripa, N. Gorla, O. Ledesma, 1989, Mutation research.

Insertion (4;11)(q27;q24q21) in a patient with essential thrombocythemia with progression to myelofibrosis.

A. Hagemeijer, F. Molinas, P. Heller, 2004, Cancer genetics and cytogenetics.

Chromosomal aberrations in human lymphocytes exposed in vitro to enrofloxacin and ciprofloxacin.

I. Larripa, N. Gorla, H. García Ovando, 1999, Toxicology letters.

Non-random distribution of spontaneous chromosome aberrations in two Bloom Syndrome patients.

I. Larripa, A. Fundia, N. Gorla, 2004, Hereditas.

Coincidence in fragile site expression with fluorodeoxyuridine and bromodeoxyuridine.

I. Larripa, A. Fundia, 1989, Cancer genetics and cytogenetics.

Heterochromatic variants and their association with neoplasias: IV. Colon adenomas and carcinomas.

I. Slavutsky, R. Meiss, I. Larripa, 1988, Cancer genetics and cytogenetics.

Sister chromatid exchange in malignant lymphomas.

I. Slavutsky, I. Larripa, M. L. D. Vinuesa, 1984, Cancer genetics and cytogenetics.

Chromosome damage induced by carboplatin (CBDCA).

M. Mudry, I. Larripa, M. González Cid, 1995, Toxicology letters.

[Molecular genetics of hemophilia A].

I. Slavutsky, C. D. De Brasi, I. Larripa, 1996, Medicina.

Genotyping the hemophilia inversion hotspot by use of inverse PCR.

C. P. Radic, C. D. De Brasi, L. Rossetti, 2005, Clinical chemistry.

Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B

A. Goodeve, C. P. Radic, C. D. De Brasi, 2012, Thrombosis and Haemostasis.

Homeologous recombination between AluSx‐sequences as a cause of hemophilia

A. Goodeve, C. D. De Brasi, L. Rossetti, 2004, Human mutation.

Reliable and cost‐effective approach for diagnosis of heterozygous F8/F9 large deletions by quantitative real‐time PCR

C. P. Radic, C. D. De Brasi, L. Rossetti, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Genotoxic action of an aqueous extract of Heliotropium curassavicum var. argentinum.

M. Mudry, M. Carballo, I. Larripa, 1992, Mutation research.

Mutagenic bioassay of certain pharmacological drugs: III. Metronidazole (MTZ).

M. Mudry, M. Carballo, I. Larripa, 1994, Mutation research.

Vinorelbine: cell cycle kinetics and differential sensitivity of human lymphocyte subpopulations.

M. González-Cid, I. Slavutsky, I. Larripa, 1997, Toxicology letters.

Mitotic arrest and anaphase aberrations induced by vinorelbine in hamster cells in vitro.

M. González-Cid, I. Larripa, M. T. Cuello, 1997, Anti-cancer drugs.

Chromosomal instability in chronic myeloid leukemia: Philadelphia breakpoints are irrespective to spontaneous breakage and fragile sites.

I. Larripa, A. Fundia, S. Acevedo, 2000, Haematologica.

Comparison of the aneugenic effect of vinorelbine and vincristine in cultured human lymphocytes.

M. González-Cid, I. Larripa, M. T. Cuello, 1999, Mutagenesis.

Spontaneous chromosome aberrations in Fanconi's anemia patients are located at fragile sites and acute myeloid leukemia breakpoints.

I. Larripa, A. Fundia, N. Gorla, 2004, Hereditas.

Sister chromatid exchanges in leukemic patients.

I. Slavutsky, I. Larripa, S. Brieux de Salum, 1985, Cancer genetics and cytogenetics.

Lack of sensitivity of sister-chromatid exchange for lymphocyte chromosomal damage detection caused by antichagasic treatment.

I. Larripa, N. Gorla, O. Ledesma, 1991, Toxicology letters.

Cytogenetic characterization of an extra structurally abnormal chromosome associated with severe mental retardation: inv dup (15) (q13).

L. Vanella, J. Lisanti, I. Slavutsky, 2004, Hereditas.

Cell cycle kinetics in hematologic diseases.

I. Slavutsky, I. Larripa, M. L. Labal de Vinuesa, 1987, Cancer genetics and cytogenetics.

Genotoxic activity of azidothymidine (AZT) in in vitro systems.

I. Larripa, M. González Cid, 1994, Mutation research.

AZT-induction of micronuclei in human lymphocyte subpopulations.

I. Slavutsky, M. Stern, I. Larripa, 1994, Toxicology letters.

Comparative Genomic Hybridization Study of de novo Myeloid Neoplasia

María V. Castuma, Palavarthy H. Rao, Susana H. Acevedo, 2000, Acta Haematologica.

Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells.

M. González-Cid, I. Larripa, Marcelo de Campos-Nebel, 2008, Mutation research.

Biologic, immunocytochemical, and cytogenetic characterization of two new human melanoma cell lines: IIB-MEL-LES and IIB-MEL-IAN.

O. Podhajcer, L. Bover, J. Mordoh, 1995, Pigment cell research.

Molecular study of the interferon genes in chronic myeloid leukemia.

I. Slavutsky, I. Larripa, I. Giere, 1995, Leukemia research.

cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib

G. Martinelli, M. Renzulli, M. Bianchini, 2006, Cancer Chemotherapy and Pharmacology.

Characterization of IIB-MEL-J: a new and highly heterogenous human melanoma cell line.

E. Medrano, J. Mordoh, I. Slavutsky, 1989, Pigment cell research.

Translocation (2;3) in hematologic malignancies.

I. Slavutsky, I. Larripa, J. Dupont, 1986, Cancer genetics and cytogenetics.

Interferon DNA polymorphism in chronic leukemia.

E. Rozenblum, J. S. Avalos, P. Rendo, 1994, Leukemia & lymphoma.

A new animal model for human undifferentiated thyroid carcinoma.

R. Cabrini, M. Pisarev, D. Gangitano, 2003, Thyroid : official journal of the American Thyroid Association.

Complex Karyotype with PH1 Chromosome in Myelodysplasia: Cytogenetic and Molecular Studies

M. Gutiérrez, I. Slavutsky, R. Bengió, 1992 .

Chromosome instability in untreated adult celiac disease patients

E. Mauriño, I. Slavutsky, L. Boerr, 1996, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[Participation of fragile sites in cancer].

I. Larripa, A. Fundia, 1996, Medicina.

Correlation between chromosome damage and apoptosis induced by fludarabine and idarubicin in normal human lymphocytes.

M. González-Cid, I. Larripa, A. Fundia, 2002, Toxicology.

Biological activity in Macrocystis pyrifera from Argentina: sodium alginate, fucoidan and laminaran. II. Genotoxicity

A. Mayer, I. Larripa, M. M. D. Pargament, 2004, Hydrobiologia.

Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR–ABL kinase domain mutations affect patient survival? First multicenter Argentinean study

M. Bianchini, R. Bengió, I. Larripa, 2011, Leukemia & lymphoma.

Polymorphic variants of GSTM1, GSTT1, and GSTP1 genes in childhood acute leukemias: A preliminary study in Argentina

G. Galimberti, G. Elena, I. Larripa, 2015, Hematology.

Transforming growth factor-β1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantation

B. Shaw, L. Feldman, G. Remaggi, 2017, Bone Marrow Transplantation.

Prognostic Implications of Cytogenetic Features in Myelodysplastic Syndromes

I. Larripa, L. Kornblihtt, C. Belli, 2013 .

Feasibility of a cost-effective approach to evaluate short tandem repeat markers suitable for chimerism follow-up

I. Larripa, A. Fundia, C. Brasi, 2012, Molecular Diagnosis.

miRNome profiling of clonal stem cells in Ph+ CML

P. Valent, P. Yankilevich, C. Furtado, 2020, bioRxiv.

Inverse PCR to perform long-distance haplotyping: main applications to improve preimplantation genetic diagnosis in hemophilia

D. Neme, E. Medina-Acosta, C. P. Radic, 2019, European Journal of Human Genetics.

Inversions of chromosome 12 in human malignancies.

C. Mecucci, H. van den Berghe, C. Doyen, 1987, Cancer genetics and cytogenetics.

Etoposide and Teniposide: In Vivo and In Vitro Genotoxic Studies

M. Carballo, I. Larripa, M. L. Labal de Vinuesa, 1992 .

The dynamic of TNF and IL6 gene expression in chronic myeloid leukemia patients reveals early responders to imatinib.

I. Larripa, C. Ferri, C. Belli, 2019, Leukemia research.

Analysis of genomic instability in adult-onset celiac disease patients by microsatellite instability and loss of heterozygosis

I. Slavutsky, J. Gómez, I. Larripa, 2008, European journal of gastroenterology & hepatology.

In vivo and in vitro cytogenetic effects of the anti-tumor agent amsacrina (AMSA).

I. Larripa, M. L. Labal de Vinuesa, M. D. Mudry de Pargament, 1984, Mutation research.

Differentia lAntigenotoxi can dCytoprotectiv eEffec tof Amifostin ei nIdarubicin-Treate dMice

I. Larripa, 2002 .

Differential antigenotoxic and cytoprotective effect of amifostine in idarubicin‐treated mice

M. González-Cid, I. Larripa, Marcelo de Campos Nebel, 2002, Environmental and molecular mutagenesis.

BCR-ABL transcripts may be detected in essential thrombocythemia but lack clinical significance.

V. Najfeld, F. Molinas, P. Heller, 2001, Blood.

Myelodysplastic syndromes in South America: A multinational study of 1080 patients

R. Pinheiro, S. Magalhães, I. Larripa, 2015, American journal of hematology.

Chromosomal damage in workers occupationally exposed to chronic low level ionizing radiation.

I. Larripa, N. Gorla, A. H. Hagelström, 1995, Toxicology letters.

Influence of TNF and IL6 gene polymorphisms on the severity of cytopenias in Argentine patients with myelodysplastic syndromes

I. Larripa, J. Arbelbide, N. Watman, 2017, Annals of Hematology.

Chromosome instability in lymphocytes from patients with celiac disease

I. Slavutsky, R. Mazure, I. Larripa, 1994, Clinical genetics.

Coincidence of cytogenetic markers in four murine cell lines.

I. Larripa, S. B. de Salum, 1981, Cancer genetics and cytogenetics.

Radiation sensitivity in retinoblastoma: current perspectives for cancer research on this disease.

I. Larripa, J. García Heras, 1988, Mutation research.

Chronic lymphocytic leukemia developing in a patient with chronic myeloid leukemia: evidence of distinct lineage-associated genomic events.

Christian Chena, I. Slavutsky, I. Larripa, 2005, Cancer genetics and cytogenetics.

Mutagenic bioassay of certain pharmacological drugs. I. Thiabendazole (TBZ).

I. Larripa, M. L. Labal de Vinuesa, M. D. Mudry de Pargament, 1987, Mutation research.

Clinical relevance of the breakpoint sites within the M-BCR in 50 patients from Argentina with chronic myeloid leukemia.

I. Larripa, I. Giere, 1996, Leukemia & lymphoma.

Development of an inverse-PCR approach for characterization of the major BCR-ABL1 breakpoint sequences on genomic DNA: proof of concept

M. Bianchini, C. D. De Brasi, I. Larripa, 2021, Clinical chemistry and laboratory medicine.

Evaluation of the primitive fraction by functional in vitro assays at the RNA and DNA level represents a novel tool for complementing molecular monitoring in chronic myeloid leukemia

P. Yankilevich, M. Bianchini, J. Mordoh, 2018, Oncotarget.

Standardization of molecular monitoring for chronic myeloid leukemia in Latin America using locally produced secondary cellular calibrators

N. Cross, M. Bianchini, J. Mordoh, 2016, Leukemia.

In vitro inhibition of murine hematopoietic progenitors and stromal cells by vinorelbine

M. González-Cid, I. Larripa, C. B. de Di Risio, 2004, Cell Biology and Toxicology.

Heterochromatic variants and their association with neoplasias: III. Multiple myeloma.

I. Slavutsky, I. Larripa, M. L. Labal de Vinuesa, 1987, Cancer genetics and cytogenetics.

Amplification of the BCR/ABL fusion gene clustered on a masked Philadelphia chromosome in a patient with myeloblastic crisis of chronic myelocytic leukemia.

I. Larripa, P. Gargallo, M. T. Cuello, 2003, Cancer genetics and cytogenetics.

GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response.

R. Bengió, I. Larripa, C. Ferri, 2016, Cancer epidemiology.

Influence of Acute Myeloid Leukemia Progression on the Prognosis of 831 Patients With Myelodysplastic Syndromes From the Argentine Database

R. Crisp, I. Larripa, J. Arbelbide, 2017, Clinical lymphoma, myeloma & leukemia.

Presence of isochromosomes in hematologic diseases.

I. Slavutsky, I. Larripa, M. L. Labal de Vinuesa, 1987, Cancer genetics and cytogenetics.

Cytogenetic and molecular studies of variant Ph' translocations.

I. Slavutsky, R. Bengió, I. Larripa, 2000, Haematologica.

Inverse shifting PCR based prenatal diagnosis of hemophilia‐causative inversions involving int22h and int1h hotspots from chorionic villus samples

C. D. De Brasi, L. Rossetti, I. Larripa, 2009, Prenatal diagnosis.

Eighteen Years of Molecular Genotyping the Hemophilia Inversion Hotspot: From Southern Blot to Inverse Shifting-PCR

C. D. De Brasi, L. Rossetti, I. Larripa, 2011, International journal of molecular sciences.

Sixteen novel hemophilia A causative mutations in the first Argentinian series of severe molecular defects.

A. Goodeve, C. D. De Brasi, L. Rossetti, 2007, Haematologica.

The CpG island in intron 22 of the factor VIII gene is predominantly methylated on the X chromosome of human males

P. Collins, D. Bowen, I. Larripa, 2002, Journal of Human Genetics.

Partial and total monosomal karyotypes in myelodysplastic syndromes: Comparative prognostic relevance among 421 patients

R. Bengió, I. Larripa, J. Arbelbide, 2011, American journal of hematology.

Functional polymorphisms of DNA repair genes in Latin America reinforces the heterogeneity of Myelodysplastic Syndrome

R. Pinheiro, H. L. Ribeiro Júnior, D. P. Borges, 2021, Hematology, transfusion and cell therapy.

Cytogenetic study of 50 de novo cases of ANLL from Argentina.

I. Slavutsky, I. Larripa, S. Acevedo, 1994, Haematologica.

Translocation t(1;5) in a case of carcinoma of the cervix.

I. Slavutsky, I. Larripa, M. Barbich, 1985, Cancer genetics and cytogenetics.